Literature DB >> 33559209

Not too fat to fight: The emerging role of macrophage fatty acid metabolism in immunity to Mycobacterium tuberculosis.

Thomas Laval1,2, Lise Chaumont1, Caroline Demangel1.   

Abstract

While the existence of a special relationship between Mycobacterium tuberculosis (Mtb) and host lipids has long been known, it remains a challenging enigma. It was clearly established that Mtb requires host fatty acids (FAs) and cholesterol to produce energy, build its distinctive lipid-rich cell wall, and produce lipid virulence factors. It was also observed that in infected hosts, Mtb constantly resides in a FA-rich environment that the pathogen contributes to generate by inducing a lipid-laden "foamy" phenotype in host macrophages. These observations and the proximity between lipid droplets and phagosomes containing bacteria within infected macrophages gave rise to the hypothesis that Mtb reprograms host cell lipid metabolism to ensure a continuous supply of essential nutrients and its long-term persistence in vivo. However, recent studies question this principle by indicating that in Mtb-infected macrophages, lipid droplet formation prevents bacterial acquisition of host FAs while supporting the production of FA-derived protective lipid mediators. Further, in vivo investigations reveal discrete macrophage phenotypes linking the FA metabolisms of host cell and intracellular pathogen. Notably, FA storage within lipid droplets characterizes both macrophages controlling Mtb infection and dormant intracellular Mtb. In this review, we integrate findings from immunological and microbiological studies illustrating the new concept that cytoplasmic accumulation of FAs is a metabolic adaptation of macrophages to Mtb infection, which potentiates their antimycobacterial responses and forces the intracellular pathogen to shift into fat-saving, survival mode.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Mycobacterium tuberculosiszzm321990; bacterial; cell lineages and subsets; fatty acid metabolism; infectious diseases; lung; macrophages; monocytes

Year:  2021        PMID: 33559209     DOI: 10.1111/imr.12952

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  6 in total

Review 1.  Host Immune-Metabolic Adaptations Upon Mycobacterial Infections and Associated Co-Morbidities.

Authors:  Alba Llibre; Martin Dedicoat; Julie G Burel; Caroline Demangel; Matthew K O'Shea; Claudio Mauro
Journal:  Front Immunol       Date:  2021-09-23       Impact factor: 7.561

2.  Dual RNA Sequencing of Mycobacterium tuberculosis-Infected Human Splenic Macrophages Reveals a Strain-Dependent Host-Pathogen Response to Infection.

Authors:  Víctor A López-Agudelo; Andres Baena; Vianey Barrera; Felipe Cabarcas; Juan F Alzate; Dany J V Beste; Rigoberto Ríos-Estepa; Luis F Barrera
Journal:  Int J Mol Sci       Date:  2022-02-04       Impact factor: 6.208

Review 3.  Progress of the Art of Macrophage Polarization and Different Subtypes in Mycobacterial Infection.

Authors:  Gai Ge; Haiqin Jiang; Jingshu Xiong; Wenyue Zhang; Ying Shi; Chenyue Tao; Hongsheng Wang
Journal:  Front Immunol       Date:  2021-11-09       Impact factor: 7.561

4.  De novo synthesized polyunsaturated fatty acids operate as both host immunomodulators and nutrients for Mycobacterium tuberculosis.

Authors:  Thomas Laval; Laura Pedró-Cos; Wladimir Malaga; Laure Guenin-Macé; Alexandre Pawlik; Véronique Mayau; Hanane Yahia-Cherbal; Océane Delos; Wafa Frigui; Justine Bertrand-Michel; Christophe Guilhot; Caroline Demangel
Journal:  Elife       Date:  2021-12-24       Impact factor: 8.140

Review 5.  In the Thick of It: Formation of the Tuberculous Granuloma and Its Effects on Host and Therapeutic Responses.

Authors:  Mark R Cronan
Journal:  Front Immunol       Date:  2022-03-07       Impact factor: 7.561

Review 6.  Lipid droplets and the host-pathogen dynamic: FATal attraction?

Authors:  Marta Bosch; Matthew J Sweet; Robert G Parton; Albert Pol
Journal:  J Cell Biol       Date:  2021-06-24       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.